Home Newsfeeds Alterity Therapeutics To Host Webcast To Discuss ATH434 Efficacy Data In Primates And Recent Clinical Progress

Alterity Therapeutics To Host Webcast To Discuss ATH434 Efficacy Data In Primates And Recent Clinical Progress

Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, will be hosting an investor

byBenzinga Newsdesk

December 4, 2023

1 minute read

Alterity Therapeutics ((ASX: ATH, NASDAQ:

Registration is required and dial in details will be sent directly upon registration.

Investors will have the opportunity to ask questions during the call, at the conclusion of the presentation. Investors are also able to submit questions in advance to Hannah Howlett at we-aualteritytherapeutics@we-worldwide.com

Truist Securities Maintains Hold on Bloom Energy, Raises Price Target to $31

By Benzinga Newsdesk

August 11, 10:37 AM

Truist Securities analyst Bronson Fleig maintains Bloom Energy (NYSE:BE) with a Hold and raises the price target from $19 to $31.

What’s Going On With Wang & Lee Group Shares

By Henry Khederian

April 24, 12:34 PM

Wang & Lee Group Ord Shs (NASDAQ: WLGS) shares are trading lower by 21.02% to $2.48 Monday afternoon, despite a lack of company-specific news. The move lower is likely due to post IPO volatility.

WLGS

Honda’s Bet On Canadian EV Hub: Reportedly Plans $11B Investment

By Shivani Kumaresan

April 25, 11:27 AM

Honda Motor reportedly announces a groundbreaking $11 billion investment to pioneer electric vehicle manufacturing in Canada. Collaborating with Canadian authorities, this strategic move signifies Honda's commitment to meeting the rising demand for electric vehicles in North America. The decision underscores a significant milestone for Canada's emergence as a pivotal player in the regional electric vehicle market.

AVDE